Indaptus Therapeutics is trading 10.1% up at $1.42 in what appears to be a technical rebound after a sharp multi-day selloff.
- There are no fresh company-specific headlines, regulatory updates, or new analyst actions reported this morning.
- The move aligns with broader risk-on market sentiment as major U.S. indices trade more than 1% higher.